A Q&A with Bree Mitchell, PhD, who leads strategic planning, scientific program development, organizational development, operations, and scientific collaboration building as the Associate Director of the OHSU Knight Cancer Institute’s Cancer Early Detection Advanced Research Center (CEDAR).
Scientists have long imagined how they could improve treatments for a host of diseases if they could better see how individual cells carry out the functions of life. That goal is now within reach at OHSU, thanks to a huge new investment in technology that allows researchers to view the makeup of molecules nearly down […]
The first time you meet Johnny Matheny is astonishing. You would be forgiven for wondering: can this be real? That’s because when Johnny reaches out to shake your hand, he’s extending his grasp with the world’s first mind-controlled robotic arm. He lost his arm to cancer, and what has replaced the missing limb is extraordinary. […]
Pictured Above: Achromatopsia clinical trial patient Annie Joiner. She’s seen the world throughout her life in black and white until a gene therapy clinical trial gave her a first glimpse of color. No one has looked at the colors on an iPhone with as much fascination as Annie Joiner has in the past couple of […]
OHSU’s Vollum Institute is a scientific powerhouse, home to some of the world’s top minds dedicated to basic neuroscience research – that critical first step in developing new treatments for neurological and psychiatric disorders. Thanks in part to significant philanthropy, one lab at the Vollum has been unusually prolific, and it’s paying off. Eric Gouaux, […]
“Our covenant with patients is to use philanthropic funds carefully, to make sure they are directed to making a difference.” Gordon Mills, M.D., Ph,D., director of precision oncology at the OHSU Knight Cancer Institutes, describes the impact that philanthropy has on cancer science.
Today is a global celebration of giving — an opportunity to support the causes that matter the most to you. Will you join us?
Give Now
